Alexey I. Kalinkin

Moskvorechie St, 1
Moscow, MOW 115522, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

DNA Methylation at a Single Locus of Human Genome Accurately Recapitulates Episignature of CREBBP-Related Rubinstein-Taybi Syndrome.

DNA Methylation at a Single Locus of Human Genome Accurately Recapitulates Episignature of CREBBP-Related Rubinstein-Taybi Syndrome.

Journal: International journal of molecular sciences

Published: August 19, 2025

Non-coding RNAs PROX1-AS1 and miR-647: Potential Interaction and Prognostic Value in Gastric Cancer.

Non-coding RNAs PROX1-AS1 and miR-647: Potential Interaction and Prognostic Value in Gastric Cancer.

Journal: Current molecular medicine

Published: December 21, 2024

Potential Regulation of ARID1A by miR-129-5p and miR-3613-3p and Their Prognostic Value in Gastric Cancer.

Potential Regulation of ARID1A by miR-129-5p and miR-3613-3p and Their Prognostic Value in Gastric Cancer.

Journal: International journal of molecular sciences

Published: December 01, 2024

Molecular Subgroups of HRD Positive Ovarian Cancer and Their Prognostic Significance.

Molecular Subgroups of HRD Positive Ovarian Cancer and Their Prognostic Significance.

Journal: International journal of molecular sciences

Published: October 13, 2024

Epigenomic Profiling Advises Therapeutic Potential of Leukotriene Receptor Inhibitors for a Subset of Triple-Negative Breast Tumors.

Epigenomic Profiling Advises Therapeutic Potential of Leukotriene Receptor Inhibitors for a Subset of Triple-Negative Breast Tumors.

Journal: International journal of molecular sciences

Published: November 01, 2023

HRD Testing of Ovarian Cancer in Routine Practice: What Are We Dealing With?

HRD Testing of Ovarian Cancer in Routine Practice: What Are We Dealing With?

Journal: International journal of molecular sciences

Published: May 24, 2023

DNA Methylation and Prospects for Predicting the Therapeutic Effect of Neoadjuvant Chemotherapy for Triple-Negative and Luminal B Breast Cancer.

DNA Methylation and Prospects for Predicting the Therapeutic Effect of Neoadjuvant Chemotherapy for Triple-Negative and Luminal B Breast Cancer.

Journal: Cancers

Published: January 12, 2023

Parental Origin of the RB1 Gene Mutations in Families with Low Penetrance Hereditary Retinoblastoma.

Parental Origin of the RB1 Gene Mutations in Families with Low Penetrance Hereditary Retinoblastoma.

Journal: Cancers

Published: August 18, 2021

Mutations in Epigenetic Regulation Genes in Gastric Cancer.

Mutations in Epigenetic Regulation Genes in Gastric Cancer.

Journal: Cancers

Published: August 06, 2021

Analysis of miRNA Expression in Patients with Rheumatoid Arthritis during Olokizumab Treatment.

Analysis of miRNA Expression in Patients with Rheumatoid Arthritis during Olokizumab Treatment.

Journal: Journal of personalized medicine

Published: September 23, 2020

Abnormal promoter DNA hypermethylation of the integrin, nidogen, and dystroglycan genes in breast cancer.

Abnormal promoter DNA hypermethylation of the integrin, nidogen, and dystroglycan genes in breast cancer.

Journal: Scientific reports

Published: August 21, 2020

DNA methylation markers panel can improve prediction of response to neoadjuvant chemotherapy in luminal B breast cancer.

DNA methylation markers panel can improve prediction of response to neoadjuvant chemotherapy in luminal B breast cancer.

Journal: Scientific reports

Published: October 01, 2019

Showing 1-12 of 15

Last Updated: 09/26/2026